P. Boden

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

Joel W. Hughes, P. Boden, B. Costall et al. · Proceedings of the National Academy of Sciences · 1990 · 504 citations · Full text

Molecular Pharmacology, Maze Test, Potent Anxiolytic Activity +12

Tolbutamide excites rat glucoreceptive ventromedial hypothallamic neurones by indirect inhibition of ATP‐K⁺ channels

Michael L.J. Ashford, P. Boden, J. Mark Treherne · British Journal of Pharmacology · 1990 · 141 citations · Full text

Membrane Resistance, Synaptic Transmission, Membrane Patches +23

Rat hippocampal slices ‘in vitro’ display spontaneous epileptiform activity following long-term organotypic culture

Chris J. McBain, P. Boden, R.G. Hill · Journal of Neuroscience Methods · 1989 · 92 citations

Rat Hippocampal Slices, Synaptic Plasticity, Molecular Neuroscience +11

Postsynaptic block of a glutamatergic synapse by low molecular weight fractions of spider venom

Andrew Bateman, P. Boden, Anne Dell et al. · Brain Research · 1985 · 80 citations

Synaptic Plasticity, Spider Venom, Molecular Neuroscience +14

Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus

P. Boden, R.G. Hill · British Journal of Pharmacology · 1988 · 75 citations · Full text

Neurotransmitter, Hypothalamic Circuits, Experimental Pharmacology +26